Marshall Wace’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-252,468
| Closed | -$768K | – | 3201 |
|
|
2024
Q4 | $768K | Sell |
252,468
-314,832
| -55% | -$1.37M | ﹤0.01% | 1858 |
|
|
2024
Q3 | $2.94M | Buy |
+567,300
| New | +$2.82M | ﹤0.01% | 1220 |
|
|
2024
Q2 | – | Sell |
-781,223
| Closed | -$3.84M | – | 3070 |
|
|
2024
Q1 | $3.84M | Buy |
+781,223
| New | +$4.62M | 0.01% | 1103 |
|
|
2023
Q4 | – | Sell |
-713,638
| Closed | -$8.19M | – | 2693 |
|
|
2023
Q3 | $8.19M | Buy |
713,638
+623,110
| +688% | +$12M | 0.02% | 713 |
|
|
2023
Q2 | $2.29M | Buy |
+90,528
| New | +$2.82M | ﹤0.01% | 1335 |
|
|
2022
Q4 | – | Sell |
-41,253
| Closed | -$1.11M | – | 3520 |
|
|
2022
Q3 | $1.11M | Buy |
41,253
+24,395
| +145% | +$495K | ﹤0.01% | 2357 |
|
|
2022
Q2 | $233K | Sell |
16,858
-105,740
| -86% | -$1.63M | ﹤0.01% | 3114 |
|
|
2022
Q1 | $2.39M | Buy |
+122,598
| New | +$1.86M | ﹤0.01% | 1947 |
|
|
2019
Q2 | – | Sell |
-30,675
| Closed | -$483K | – | 1931 |
|
|
2019
Q1 | $483K | Buy |
+30,675
| New | +$532K | ﹤0.01% | 1146 |
|
